| Autor: |
Reimer JMB; Isala, afd. Neurologie, Zwolle.; Contact: J. M.B. Reimer (j.m.b.reimer@isala.nl)., Deodatus JA; Isala, afd. Spoedeisende Hulp, Zwolle., Nguyen TKM; Isala, afd. Radiologie, Zwolle., den Hertog MH; Isala, afd. Neurologie, Zwolle. |
| Jazyk: |
Dutch; Flemish |
| Zdroj: |
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2021 Feb 18; Vol. 165. Date of Electronic Publication: 2021 Feb 18. |
| Abstrakt: |
Cerebral amyloid angiopathy (CAA) is a degenerative neurovascular disease in which the protein amyloid-beta accumulates in the vessel wall of cortical and leptomeningeal arteries. This may lead to acute lobar cerebral haemorrhage, which in case of CAA is fatal in 10-30% of cases. CAA may also present with transient focal neurological episodes (TFNE), the symptoms of which may mimic a transient ischaemic attack (TIA). Distinction between the two has important implications for therapy, as antithrombotics are relatively contra-indicated in CAA, but indicated after a TIA. We describe a patient with transient focal neurological deficits who was initially treated with antithrombotic therapy for a suspected TIA. Eventually, the diagnosis CAA was made and antithrombotic treatment was ceased. This case stresses the importance of considering the diagnosis CAA with TFNE in patients presenting with transient neurological deficits, in order to avoid an unnecessarily increased risk of symptomatic and possibly fatal cerebral haemorrhage. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
